Skip to main content
. Author manuscript; available in PMC: 2018 Oct 10.
Published in final edited form as: J Control Release. 2017 Mar 21;263:200–210. doi: 10.1016/j.jconrel.2017.03.033

Figure 3.

Figure 3

Composition of sHDL nanodisc cancer vaccine. (a) Antigen peptides and adjuvant Cp G are conjugated on nanodiscs. (b) After subcutaneous injection, this nanovaccine can migrate efficiently into draining lymph nodes, and activate tumor-specific T cell response. Reprinted with permission from Ref. 103.